Regorafenib, C-kit Mutated Malignant Melanoma, 2nd Line Therapy

计划入组 36 人 · 首次发布于 2015 年 7 月 17 日

A Study of the c-Kit Specific Antibody-Drug Conjugate NN3201 for Advanced and/or Metastatic Solid Tumors Known to Express c-Kit

计划入组 67 人 · 首次发布于 2025 年 2 月 3 日

Regorafenib in GIST With Secondary C-KIT Exon 17 Mutation

计划入组 19 人 · 首次发布于 2015 年 11 月 17 日

P-ckit-ALLO1

NN-3202

Anti-c-kit humanised IgG1/κ antibody-maitansine conjugate (Novartis)

C & C Oxygen Company

United States

KIT COSMETICS PTY LTD

Australia

BEST DENTAL KIT LLC

United States

Alys Pharmaceuticals Initiates First-in-Class Mast Cell Selective c-Kit Inhibitor Trial for Chronic Urticaria

Alys Pharmaceuticals Advances First-in-Class Mast Cell-Selective c-Kit Inhibitor ALY-301 to Clinical Trials for Cold Urticaria

Jasper Therapeutics Doses First Patient in Phase 1b/2a Briquilimab Asthma Study